Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used-Reference-Cited by-同舟云学术

Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used

Published:2008-12 Issue:12 Volume:52 Page:4528-4528
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Prakash V.¹,Lewis J. S.²,Jorgensen J. H.³

Affiliation:

1. San Antonio Military Medical Center  Infectious Disease Service  San Antonio, Texas

2. Department of Medicine  The University of Texas Health Science Center  Pharmacy Service  University Hospital  San Antonio, Texas

3. Department of Pathology  University of Texas Health Science Center  7703 Floyd Curl Drive  San Antonio, Texas 78229-3900

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00904-08

Reference7 articles.

1. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2006

2. Hidayat, L. K., D. I. Hsu, R. Quist, K. A. Shriner, and A. Wong-Beringer. 2006. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Arch. Intern. Med.166:2138-2144.

3. Maclayton, D. O., K. J. Suda, K. A. Coval, C. B. York, and K. W. Garey. 2006. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 μg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin. Ther.28:1208-1216.

4. Moise-Broder, P. A., A. Forrest, M. C. Birmingham, and J. J. Schentag. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin. Pharmacokinet.43:925-942.

5. Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis.15:1700-1705.

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations;European Journal of Microbiology and Immunology;2024-05-14

2. Staphylococcus aureus response and adaptation to vancomycin;Advances in Microbial Physiology;2024

3. Staphylococcal Infection;The Infectious Diseases Consult Handbook;2023

4. Method Development: The Antioxidant and Antifungal Activity of the Isolated Component from the Ethanolic Extract of Tecoma stans Leaves Using Flash Chromatography;Separations;2022-10-18

5. Controlled Release Mechanism of Vancomycin from Double-Layer Poly-L-Lactic Acid-Coated Implants for Prevention of Bacterial Infection;Polymers;2022-08-26